Items where authors include "Mundayat, R"

Article

Orbai, A-M, Mease, PJ, Helliwell, PS orcid.org/0000-0002-4155-9105 et al. (4 more authors) (2022) Effect of tofacitinib on dactylitis and patient-reported outcomes in patients with active psoriatic arthritis: post-hoc analysis of phase III studies. BMC Rheumatology, 6 (1). 68. ISSN 2520-1026

Conference or Workshop Item

Mease, P, Orbai, A-M, FitzGerald, O et al. (5 more authors) (2021) Efficacy of Tofacitinib on Enthesitis in Patients with Active Psoriatic Arthritis. In: ACR Convergence 2021, 05-09 Nov 2021, Online.

Orbai, AM, Mease, PJ, Helliwell, P orcid.org/0000-0002-4155-9105 et al. (5 more authors) (2021) Efficacy of Tofacitinib on Dactylitis in Individual Digits in Patients with Active Psoriatic Arthritis. In: EULAR 2021 Virtual Congress (Rheumatology), 02-05 Jun 2021, Virtual.

Orbai, A-M, Mease, P, Helliwell, P orcid.org/0000-0002-4155-9105 et al. (5 more authors) (2020) Efficacy of Tofacitinib on Dactylitis in Individual Digits in Patients with Active Psoriatic Arthritis. In: ACR Convergence 2020, 05-09 Nov 2020, Virtual.

Ritchlin, CT, Ogdie, A, Giles, JT et al. (9 more authors) (2020) AB0827 IMPACT OF BASELINE BODY MASS INDEX ON THE EFFICACY AND SAFETY OF TOFACITINIB IN PATIENTS WITH PSORIATIC ARTHRITIS. In: EULAR 2020, 03-06 Jun 2020, Online.

Ritchlin, C, Ogdie, A, Giles, J et al. (9 more authors) (2019) Impact of Baseline Body Mass Index on the Efficacy and Safety of Tofacitinib in Patients with Psoriatic Arthritis. In: 2019 ACR/ARP Annual Meeting, 08-13 Nov 2019, Atlanta, Georgia, USA.